Ozarelix

DB12581InvestigationalSmall molecule

Ozarelix has been used in trials studying the treatment of Prostate Cancer, Benign Prostatic Hypertrophy, and Benign Prostatic Hyperplasia (BPH).

Mechanism: Pharmacologically active on Gonadotropin-releasing hormone receptor
Curator reviewed
Formula / weight: C₇₂H₉₆ClN₁₇O₁₄ · 1459.12 g/mol (avg)
Code names: D-63 153

Resolves to

Compound

UNIIQ1IF8M2YL3CAS295350-45-7PubChem25080293

Structure

InChIKeyKATZUZNTRINHDT-HALMFYTRSA-NSMILES

[H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCCC)N([H])C(=O)[C@@H](CCCCN([H])C(=O)N([H])[H])N([H])C(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)N([H])C(=O)[C@@H](CC1=CN=CC=C1)N([H])C(=O)[C@@H](CC1=CC=C(Cl)C=C1)N([H])C(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)N([H])C(C)=O)C(=O)N1CCC[C@H]1C(=O)N([H])[C@H](C)C(=O)N([H])[H]

Targets

P30968GNRHR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ozarelix, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account